Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Decibel Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 39 | 38 | −1 |
| Shares | 17.5M | 15.5M | −2.03M (−11.6%) |
| Value | $35.8M | $46.7M | +$10.8M (+30.2%) |
New holders (3)
Institutions that held Decibel Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 189,386 | $571.9K | 0.01% |
| Baird Financial Group, Inc. | 14,900 | $45.0K | 0.00% |
| UBS Group AG | 46 | $139 | 0.00% |
Sold out (4)
Institutions that held Decibel Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Citadel Advisors LLC | 1,787,311 | $3.66M |
| Ergoteles LLC | 23,480 | $48.1K |
| Charles Schwab Investment Management Inc | 10,345 | $21.2K |
| Clear Street Markets LLC | 1,500 | $3.00K |